NCT05352035Recruiting
Multiomics Tumor Evolution Model of NSCLC
A Multiomics Study of Tumor Evolution Characteristics and Prognostic Model in Early-stage Non-small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 30 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to determine the evolutionary mechanism of early-stage non-small cell lung cancer and establish an accurate prognostic model and a recurrence monitoring system by multiomics analysis, which can be helpful for the individual and whole management of lung cancer patients and improve the overall prognosis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 23 Apr 2022
- Start date
- 20 Apr 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Peking University People's Hospital
- Diseases
- Lung cancer
- NCT number
- NCT05352035
What you commit to
- Study type: Observational
- Planned participants: 300
- From 20 Apr 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Evidence of distant metastasis before surgery;
Other illness
- History of other malignant tumors;
Other
- Insufficient tumor tissue or blood sample for study use;
- Clinical-pathologic data, imaging data or follow-up date is not available;
- Other judgments by the Investigator that the patient should not participate in the study.
Who the study is looking for
- Age ≥ 18 years old;
- Early-stage NSCLC patients underwent radical surgical resection;
- Sufficient tumor tissue and blood sample for study use;
- Available clinical-pathologic data, imaging data and follow-up date;
- Written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University People's Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.